跳至主要内容
临床试验/ACTRN12622000766718
ACTRN12622000766718招募中未知

A cluster randomised controlled trial evaluating the efficacy of a practice nurse-coordinated intervention targeting treatable traits in moderate-severe COPD in primary care, compared with usual care, and its effect on health-related quality of life (HRQoL) and hospitalisations/emergency department (ED) visits

Monash University0 个研究点目标入组 400 人开始时间: 2022年5月30日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Community dwelling adults aged 18 years and above with a history of mild-severe COPD and with a history of at least one exacerbation in the previous 24 months (based on self-reported COPD-related hospitalisation or use of short course oral steroids and/or antibiotics) will be eligible.

排除标准

  • Those unable to provide informed consent e.g. cognitive impairment, unable to communicate in English, with difficulty following the intervention, with a terminal illness (anticipated survival <12 months), symptoms suggesting unstable heart disease, or contraindications to spirometry as per standard guidelines will be excluded.

研究者

相似试验

Targeting Treatable Traits (TTs) in Chronic... | 临床试验